Adenylosuccinic acid

Description: Adenylosuccinic acid (Adenylosuccinate, Aspartyl adenylate) is a purine ribonucleoside monophosphate that plays a role in the nucleotide cycle metabolite. It has potential for the study of Duchenne muscular dystrophy (DMD)[1] and can be converted into fumaric acid through adenylosuccinate lyase. Target: Others. Smiles: O[C@H]1[C@](N2C=3C(N=C2)=C(N[C@@H](CC(O)=O)C(O)=O)N=CN3)(O[C@H](COP(=O)(O)O)[C@H]1O)[H]. References: Timpani CA, et al. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.Sci Rep. 2020 Jan 24,10(1):1125.